Las personas que tienen un IMC de ms de 30 tienen una indicacin de tratamiento farmacolgico, adems de las pautas higinico-dietticas (alimentacin y actividad fsica)
GLP-1 drugs might also promote weight loss by reducing the amount of visceral fat the type of fat that surrounds organs and can contribute to conditions like obesity , fatty liver disease, and diabetes
While Medicare does not cover medications when prescribed solely for weight loss, the Wegovy pill may be covered if prescribed for cardiovascular risk reduction
Originally studied for its tanning properties, Melanotan II has also been noted for its impact on sexual function, making it a topic of interest in both aesthetics and wellness medicine
Redox-sensitive fluorescent nanoparticles for biovisualization of malignant tumors
The fork in the road is whether the plan covers GLP-1s for obesity at all, and that question is best answered up front rather than after multiple PA submissions
